NEUWAY Pharma GmbH

NEUWAY PHARMA GmbH is a preclinical biotech company based in Bonn, Germany. The company is focusing on the development of innovative therapeutics for treatment of brain diseases based on its proprietary drug delivery technology EnPC®.

NEUWAY was founded in April 2014 as the first spin-off from Life Science Inkubator (LSI) GmbH, Bonn, Germany, where it had been incubated and supported.

The company was seeded by Wellington Partners, LSI, Kreditanstalt für Wiederaufbau (KfW) and several private shareholders. In addition to a strong Advisory Board, NEUWAY has gained the support of leading drug developers on its Scientific Board.